Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionBlume Capital Management, Inc.
Latest Disclosed Ownership3,195 shares
Latest Disclosed Value $ 445,288
Blume Capital Management, Inc. ownership in GILD / Gilead Sciences, Inc.

On May 1, 2026 - Blume Capital Management, Inc. filed a 13F-HR form disclosing ownership of 3,195 shares of Gilead Sciences, Inc. (CH:GILD) valued at $445,288 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 3,195 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM 375558103 3,195 0 0.00 445 13.52 0.0757
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,195 -250 -7.26 392 2.62 0.0713
2025-11-06 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,445 -81 -2.30 382 -2.05 0.0727
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 3,526 -7 -0.20 391 -1.27 0.0787
2025-05-06 2025-03-31 13F GILEAD SCIENCES COM 375558103 3,533 13 0.37 396 21.54 0.0886
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 3,520 0 0.00 325 10.17 0.0728
2024-10-29 2024-09-30 13F GILEAD SCIENCES COM 375558103 3,520 0 0.00 295 22.41 0.0660
2024-08-05 2024-06-30 13F GILEAD SCIENCES COM 375558103 3,520 0 0.00 242 -6.23 0.0582
2024-05-02 2024-03-31 13F GILEAD SCIENCES COM 375558103 3,520 0 0.00 258 -9.82 0.0623
2024-05-02 2023-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 3,520 -80 -2.22 285 5.95 0.0745
2024-02-07 2023-12-31 13F GILEAD SCIENCES COM 375558103 3,520 -80 285 0.0745
2024-05-02 2023-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,600 -2,200 -37.93 270 -39.82 0.0798
2023-11-03 2023-09-30 13F GILEAD SCIENCES COM 375558103 3,600 -2,200 270 0.0798
2024-05-02 2023-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 5,800 0 0.00 447 -7.07 0.1308
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 5,800 0 447 0.1308
2024-05-02 2023-03-31 13F/A-1 Gilead Sciences COM 375558103 5,800 -909 -13.55 481 -16.35 0.1525
2023-05-08 2023-03-31 13F Gilead Sciences COM 375558103 5,800 -909 481 0.1525
2023-02-08 2022-12-31 13F Gilead Sciences COM 375558103 6,709 -150 -2.19 576 35.93 0.1945
2022-11-15 2022-09-30 13F GILEAD SCIENCES COM 375558103 6,859 189 2.83 423 2.67 0.1593
2022-08-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 6,670 1,091 19.56 412 24.10 0.1627
2022-05-12 2022-03-31 13F Gilead Sciences COM 375558103 5,579 2,000 55.88 332 27.69 0.1095
2022-02-07 2021-12-31 13F Gilead Sciences COM 375558103 3,579 120 3.47 260 7.44 0.0858
2021-11-12 2021-09-30 13F Gilead Sciences COM 375558103 3,459 -300 -7.98 242 -6.56 0.0885
2021-08-10 2021-06-30 13F Gilead Sciences COM 375558103 3,759 -100 -2.59 259 4.02 0.0947
2021-05-10 2021-03-31 13F Gilead Sciences COM 375558103 3,859 709 22.51 249 35.33 0.0980
2021-02-09 2020-12-31 13F Gilead Sciences COM 375558103 3,150 -200 -5.97 184 -13.21 0.0787
2020-11-12 2020-09-30 13F Gilead Sciences COM 375558103 3,350 0 0.00 212 -17.83 0.1075
2020-08-06 2020-06-30 13F Gilead Sciences COM 375558103 3,350 0 0.00 258 3.20 0.1430
2020-05-07 2020-03-31 13F Gilead Sciences COM 375558103 3,350 -165 -4.69 250 9.65 0.1601
2020-02-05 2019-12-31 13F Gilead Sciences COM 375558103 3,515 -100 -2.77 228 -0.44 0.1116
2019-11-12 2019-09-30 13F Gilead Sciences COM 375558103 3,615 0 0.00 229 -6.15 0.1144
2019-07-29 2019-06-30 13F Gilead Sciences COM 375558103 3,615 165 4.78 244 8.93 0.1235
2019-05-06 2019-03-31 13F Gilead Sciences COM 375558103 3,450 0 0.00 224 3.70 0.1176
2019-02-05 2018-12-31 13F Gilead Sciences COM 375558103 3,450 -100 -2.82 216 -21.17 0.1233
2018-11-02 2018-09-30 13F Gilead Sciences COM 375558103 3,550 0 0.00 274 9.16 0.1432
2018-08-02 2018-06-30 13F Gilead Sciences COM 375558103 3,550 0 0.00 251 -5.99 0.1369
2018-05-04 2018-03-31 13F Gilead Sciences COM 375558103 3,550 -700 -16.47 267 -12.17 0.1485
2018-02-09 2017-12-31 13F Gilead Sciences COM 375558103 4,250 -450 -9.57 304 -20.21 0.1556
2018-02-14 2017-09-30 13F/A-1 Gilead Sciences COM 375558103 4,700 200 4.44 381 19.44 0.2015
2017-11-13 2017-09-30 13F Gilead Sciences COM 375558103 4,700 200 381
2017-08-08 2017-06-30 13F Gilead Sciences COM 375558103 4,500 -850 -15.89 319 -12.12 0.1811
2017-05-12 2017-03-31 13F Gilead Sciences COM 375558103 5,350 550 11.46 363 5.52 0.2101
2017-01-30 2016-12-31 13F Gilead Sciences COM 375558103 4,800 -1,050 -17.95 344 -25.70 0.2067
2016-11-07 2016-09-30 13F Gilead Sciences COM 375558103 5,850 350 6.36 463 0.87 0.2836
2016-08-11 2016-06-30 13F/A-1 Gilead Sciences COM 375558103 5,500 50 0.92 459 -8.38 0.3028
2016-08-04 2016-06-30 13F Gilead Sciences COM 375558103 1,800 459
2016-05-12 2016-03-31 13F Gilead Sciences COM 375558103 5,450 400 7.92 501 -1.96 0.3460
2016-05-26 2015-12-31 13F/A-1 Gilead Sciences COM 375558103 5,050 -1,400 -21.71 511 -19.27 0.3613
2016-02-08 2015-12-31 13F GILEAD SCIENCES COM 375558103 5,050 511
2015-11-05 2015-09-30 13F GILEAD SCIENCES COM 375558103 6,450 -46 -0.71 633 -16.82 0.5135
2015-08-11 2015-06-30 13F GILEAD SCIENCES COM 375558103 6,496 -17,313 -72.72 761 -67.42 0.5757
2015-05-05 2015-03-31 13F GILEAD SCIENCES COM 375558103 23,809 18,619 358.75 2,336 377.71 1.6198
2015-02-10 2014-12-31 13F GILEAD SCIENCES COM 375558103 5,190 290 5.92 489 -6.32 0.3447
2014-11-12 2014-09-30 13F GILEAD SCIENCES COM 375558103 4,900 0 0.00 522 28.57 0.4062
2014-07-29 2014-06-30 13F GILEAD SCIENCES COM 375558103 4,900 0 0.00 406 17.00 0.3187
2014-05-13 2014-03-31 13F GILEAD SCIENCES COM 375558103 4,900 -500 -9.26 347 -14.53 0.2755
2014-02-14 2013-12-31 13F GILEAD SCIENCES COM 375558103 5,400 5,400 406 0.3358
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.